Today’s top gainers include the company Celgene Corporation (NASDAQ:CELG) which is in the industry Biotechnology, gaining 0.26% today. In the last week its performance is -1.77%, and -1.06% for the past quarter. Currently, Celgene Corporation, CELG has a target price of 140.61, so today’s gain of 0.26% is a significant step towards its target price. The GAP today is therefore -0.03%.
Celgene Corporation (NASDAQ:CELG), has a market cap of 91.82 B, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.50%.
At the current price of 117.4, it has a dividend yield of *TBA, and its target price is 140.61. This is with a profit margin of 18.30%, and total debt/equity of 1.87. Celgene Corporation (NASDAQ:CELG) has a P/E of 44.22, as well as a forward P/E of 13.33.
With a current EPS of 2.66, and a forecasted EPS growth for next year at 20.92%,Celgene Corporation (NASDAQ:CELG) has had a EPS growth for the past five years at 11.80%. For the next five years EPS growth is projected to be 20.71%.
Performance for the year is 16.15%. Since its IPO date on 3/26/1990, the total performance to date is 1.43%.
Volume today for Celgene Corporation (NASDAQ:CELG), is 3643722, while its average volume is 3539.33. Whilst the total gain today was 0.26%, it did have a day high of -8.02%.
Volatility for this week has been at 1.23%, and 1.43% for the month. The 52-week low for Celgene Corporation, CELG has been 24.34%, while the 52-week-high has reached -8.02%.
Looking at its return of investments, which is 11.70%, and its return on assets is 7.80%. Celgene Corporation (NASDAQ:CELG) has an operating margin of 24.80%. With a sales growth of 17.90% quarter over quarter. Bearing in mind that Celgene Corporation, CELG is in the sector Healthcare, its long-term debt/equity is 1.8, and has a current ratio of 4.4 and 4.2 for quick ratio.
So what is the value of Celgene Corporation? Well its PEG is 2.14, and the P/S is 7.86, along with a P/B of 11.97. Meanwhile it has a p/cash of 10.36.